HERITAGE INVESTORS MANAGEMENT CORP – Neurocrine Biosciences, Inc. Transaction History
HERITAGE INVESTORS MANAGEMENT CORP portfolio value:
$760,000
portfolio value
HERITAGE INVESTORS MANAGEMENT CORP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.54% | -340 shares | 30K | $106.21 | 7.15K |
| Q2 2022 | share | Decrease | -8.01% | -652 shares | -33K | $97.48 | 7.49K |
| Q1 2022 | share | 0.00% | 0 shares | 69K | $93.75 | 8.14K | |
| Q4 2021 | share | 0.00% | 0 shares | -87K | $84.63 | 8.14K | |
| Q3 2021 | share | 0.00% | 0 shares | -11K | $95.91 | 8.14K | |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 8.14K | |
| Q1 2021 | share | 0.00% | 0 shares | 11K | $97.25 | 8.14K | |
| Q4 2020 | share | 0.00% | 0 shares | -2K | $95.85 | 8.14K | |
| Q3 2020 | share | 0.00% | 0 shares | -210K | $96.16 | 8.14K | |
| Q2 2020 | share | Increase | +68.31% | 3.30K shares | 574K | $122 | 8.14K |
| Q1 2020 | share | Increase | +110.35% | 2.53K shares | 172K | $86.55 | 4.83K |
| Q4 2019 | share | 0.00% | 0 shares | 40K | $107.49 | 2.3K | |
| Q3 2019 | share | Increase | 0.00% | 2.3K shares | 207K | $90.11 | 2.3K |
| Q2 2019 | share | Decrease | -100.00% | -2.3K shares | -203K | $84.43 | 0 |
| Q1 2019 | share | Increase | 0.00% | 2.3K shares | 203K | $88.1 | 2.3K |